If you’re interested in quantitative potency assessment of your product, listen in and learn how GARDskin Dose-Response threshold concentrations can be linked to LLNA´s EC3 values and human sensitizing potency. […]
Given the huge interest in our previous webinar on GARDskin Dose-Response, we are pleased to offer you a new opportunity to get to know this novel in vitro test. The […]
MVA Medtech Network gathers the region’s medtech industry to create new partnerships and business opportunities. Joining the network is free of charge but is limited to Medicon Valley Alliance members. However, […]
SenzaGen have partnered with XCellR8 to bring you this half hour webinar to explain more about how the GARD methods work, from determining potency to animal-product-free solutions. You will learn […]
13.00 Session 5. Cosmetics Assessment Chair: Hanan Osman-Ponchet (PKDERM) Talk: Andy Forreryd, Dose-response analysis in GARD for assessment of skin sensitizer potency
Biocompatibility testing in Medical Devices Conference 2020 will give you the unique opportunity to discuss the most pressing issues and meet the representatives of the biggest companies and leaders from Biocompatibility and […]
Senzagen will be presenting a poster at the ASCCT meeting on Oct 20 from 4:45-6 pm EDT. Come join us to learn about how the GARDskin Dose-Response assay can be […]
In Vitro Skin Sensitization Testing with Human Relevance and High Accuracy In this webinar you will learn how combining genomics and machine learning provides a highly accurate in vitro method for assessment […]
Wednesday, October 28, 2020 11:05 a.m. PT Joshua Schmidt, SenzaGen, Inc. "Leveraging in vitro to forecast in vivo success"
New Approach Methodology Use for Regulatory Application (NURA) in collaboration with the Association for the Advancement of Alternatives Assessment (A4) is hosting two half day trainings to explore practical solutions for the […]
